157 related articles for article (PubMed ID: 25985271)
1. Fertility and fragrance: another cause of Kallmann syndrome.
Melmed S
J Clin Invest; 2015 Jun; 125(6):2275-8. PubMed ID: 25985271
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.
Cariboni A; André V; Chauvet S; Cassatella D; Davidson K; Caramello A; Fantin A; Bouloux P; Mann F; Ruhrberg C
J Clin Invest; 2015 Jun; 125(6):2413-28. PubMed ID: 25985275
[TBL] [Abstract][Full Text] [Related]
3. Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.
Marcos S; Monnier C; Rovira X; Fouveaut C; Pitteloud N; Ango F; Dodé C; Hardelin JP
Hum Mol Genet; 2017 Jun; 26(11):2006-2017. PubMed ID: 28334861
[TBL] [Abstract][Full Text] [Related]
4. Kallmann syndrome and idiopathic hypogonadotropic hypogonadism: The role of semaphorin signaling on GnRH neurons.
Cariboni A; Balasubramanian R
Handb Clin Neurol; 2021; 182():307-315. PubMed ID: 34266601
[TBL] [Abstract][Full Text] [Related]
5. β-Klotho sustains postnatal GnRH biology and spins the thread of puberty.
Misrahi M
EMBO Mol Med; 2017 Oct; 9(10):1334-1337. PubMed ID: 28778954
[TBL] [Abstract][Full Text] [Related]
6. CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration.
Hutchins BI; Kotan LD; Taylor-Burds C; Ozkan Y; Cheng PJ; Gurbuz F; Tiong JD; Mengen E; Yuksel B; Topaloglu AK; Wray S
Endocrinology; 2016 May; 157(5):1956-66. PubMed ID: 27014940
[TBL] [Abstract][Full Text] [Related]
7. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
[TBL] [Abstract][Full Text] [Related]
8. Reversal of idiopathic hypogonadotropic hypogonadism.
Raivio T; Falardeau J; Dwyer A; Quinton R; Hayes FJ; Hughes VA; Cole LW; Pearce SH; Lee H; Boepple P; Crowley WF; Pitteloud N
N Engl J Med; 2007 Aug; 357(9):863-73. PubMed ID: 17761590
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the KAL gene in female patients with gonadotropin-releasing hormone deficiency.
Lee SH; Han JH; Cho SW; Lee WH; Cha KY; Lee MH
Yonsei Med J; 2004 Feb; 45(1):107-12. PubMed ID: 15004876
[TBL] [Abstract][Full Text] [Related]
10. [GnRH deficiency: new insights from genetics].
Kottler ML; Hamel A; Malville E; Richard N
J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
[TBL] [Abstract][Full Text] [Related]
11. GnRH, anosmia and hypogonadotropic hypogonadism--where are we?
Forni PE; Wray S
Front Neuroendocrinol; 2015 Jan; 36():165-77. PubMed ID: 25306902
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone (GnRH) deficiency under treatment: psychological and sexual functioning impacts.
Georgopoulos NA; Armeni AK; Stamou M; Kentrou A; Tsermpini EE; Iconomou G; Hyphantis T; Assimakopoulos K
Hormones (Athens); 2018 Sep; 17(3):383-390. PubMed ID: 30168087
[TBL] [Abstract][Full Text] [Related]
13. The genetics of hypogonadotropic hypogonadism.
Bhagavath B; Layman LC
Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
[TBL] [Abstract][Full Text] [Related]
14. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human.
Waldstreicher J; Seminara SB; Jameson JL; Geyer A; Nachtigall LB; Boepple PA; Holmes LB; Crowley WF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4388-95. PubMed ID: 8954047
[TBL] [Abstract][Full Text] [Related]
15. The role of semaphorin signaling in the etiology of hypogonadotropic hypogonadism.
Lettieri A; Oleari R; Gimmelli J; ANDRé V; Cariboni A
Minerva Endocrinol; 2016 Jun; 41(2):266-78. PubMed ID: 26940457
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of impaired GnRH neuron development and function.
Kim HG; Bhagavath B; Layman LC
Neurosignals; 2008; 16(2-3):165-82. PubMed ID: 18253056
[TBL] [Abstract][Full Text] [Related]
17. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome.
Hardelin JP; Julliard AK; Moniot B; Soussi-Yanicostas N; Verney C; Schwanzel-Fukuda M; Ayer-Le Lievre C; Petit C
Dev Dyn; 1999 May; 215(1):26-44. PubMed ID: 10340754
[TBL] [Abstract][Full Text] [Related]
18. Forebrain gonadotropin-releasing hormone neuronal development: insights from transgenic medaka and the relevance to X-linked Kallmann syndrome.
Okubo K; Sakai F; Lau EL; Yoshizaki G; Takeuchi Y; Naruse K; Aida K; Nagahama Y
Endocrinology; 2006 Mar; 147(3):1076-84. PubMed ID: 16293668
[TBL] [Abstract][Full Text] [Related]
19. Kallmann syndrome in females: gonadotropin versus GnRH to induce fertility.
Imai A; Tamaya T
J Med; 1996; 27(3-4):237-40. PubMed ID: 8982973
[TBL] [Abstract][Full Text] [Related]
20. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.
Pitteloud N; Acierno JS; Meysing AU; Dwyer AA; Hayes FJ; Crowley WF
J Clin Endocrinol Metab; 2005 Mar; 90(3):1317-22. PubMed ID: 15613419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
